5 research outputs found
The nowcasting SAF products and services: recent improvements in the new SW packages PPS v2018 and GEO v2018 and future plans
PresentaciĂłn realizada en la 3rd European Nowcasting Conference, celebrada en la sede central de AEMET en Madrid del 24 al 26 de abril de 2019
Salvage I-125 brachytherapy for locally-recurrent prostate cancer after radiotherapy
PurposeRetrospective, single-institution analysis of clinical outcomes and treatment-related toxicity in patients treated with salvage I-125 low-dose rate (LDR) brachytherapy (BT) for locally-recurrent prostate cancer after radiotherapy.Materials and methodsBetween 2008 and 2018, 30 patients with biopsy-confirmed prostate cancer recurrence underwent salvage treatment with I-125 LDR-BT. Of these 30 patients, 14 were previously treated with primary external beam radiotherapy (EBRT; median dose, 73âŻGy) and 16 with primary I-125 LDR-BT (145âŻGy and 160âŻGy in 14 and 2 cases, respectively). At seed implantation, the mean age was 75.8 years, with a median Gleason score of 7 and pre-salvage PSA o